Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Phospho-MET/c-Met/HGFR (Tyr1349) Antibody (R1L69)

Catalog #:   RHC34203 Specific References (10) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IP, WB
Accession: P08581
Overview

Catalog No.

RHC34203

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IP: 1:20, WB: 1:500-1:1000

Target

Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P08581

Applications

IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1L69

Data Image
  • Western blot
    Western blot analysis of Phospho-Met (c-Met) (Tyr1349) in Hela, A549 lysates using Phospho-c-Met (Tyr1349) antibody.
References

Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer., PMID:37586448

Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors., PMID:34164713

[Effect of c-Met inhibitor AMG-102 on radiosensitivity in laryngeal squamous carcinoma cells]., PMID:31874548

Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer., PMID:30638462

Crizotinib and erlotinib inhibits growth of c-Met+/EGFRvIII+ primary human glioblastoma xenografts., PMID:29803091

Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression., PMID:25522765

Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time., PMID:25418580

Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy., PMID:21774103

Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma., PMID:16186806

Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue., PMID:15504247

Datasheet
$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Phospho-MET/c-Met/HGFR (Tyr1349) Antibody (R1L69) [RHC34203]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only